According to Fresenius Medical Care's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.586745. At the end of 2023 the company had a P/S ratio of 0.5800.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.5800 | 23.43% |
2022 | 0.4699 | -49.38% |
2021 | 0.9282 | -21.18% |
2020 | 1.18 | 4.72% |
2019 | 1.12 | 9.99% |
2018 | 1.02 | -35.21% |
2017 | 1.58 | 16.96% |
2016 | 1.35 | -9.74% |
2015 | 1.49 | 8.89% |
2014 | 1.37 | -9.65% |
2013 | 1.52 | -3.39% |
2012 | 1.57 | -0.52% |
2011 | 1.58 | 11.86% |
2010 | 1.41 | 2.98% |
2009 | 1.37 | 6.49% |
2008 | 1.29 | -20.05% |
2007 | 1.61 | 2.89% |
2006 | 1.57 | 4.35% |
2005 | 1.50 | 55.06% |
2004 | 0.9683 | 4.03% |
2003 | 0.9308 | 72.62% |
2002 | 0.5392 | -27.22% |
2001 | 0.7408 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Amgen AMGN | 5.47 | 831.84% | ๐บ๐ธ USA |
Baxter BAX | 1.14 | 94.96% | ๐บ๐ธ USA |
DaVita DVA | 1.05 | 78.26% | ๐บ๐ธ USA |
IDEXX Laboratories IDXX | 11.1 | 1,788.54% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | 1.67 | 184.06% | ๐บ๐ธ USA |
Teleflex TFX | 3.24 | 452.69% | ๐บ๐ธ USA |
LabCorp LH | 1.33 | 125.93% | ๐บ๐ธ USA |
Rockwell Medical
RMTI | 0.6265 | 6.77% | ๐บ๐ธ USA |